• Lionbridge
• 19 Aug, 2019

The target market for conducting global clinical trials has changed significantly, moving beyond pharmaceutical early adopters to the mainstream marketplace. This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial.
Read more...